Peptide Therapeutics Market Report

China Peptide Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 24, 2023
  • PAGES：225
  • REPORT CODE：GMM1754012
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Peptide Therapeutics can be widely used to treat cancer, metabolic disorders, and cardiovascular diseases. When the level of endogenous peptide tends to decline, peptide drugs will be used as an alternative therapy to supplement peptide hormones. Clinical global authorities in the United States, Europe and Japan have approved 60 peptide drugs.

    During the forecast period, the Peptide Therapeutics market will achieve significant market growth, culminating in a compound annual growth rate of 8.4%. Cell-penetrating peptides will bring a broader prospect for the Peptide Therapeutics market. Cell-penetrating peptides, known as ideal transporters, assist therapeutic drugs in a nontoxic and simple manner, including proteins, oligonucleotides, nanoparticles, and so on.

    The increase in the incidence rate of cancer and metabolic diseases such as osteoporosis, obesity and diabetes is a major factor driving the growth of Peptide Therapeutics market during the forecast period. In addition, the growing population base affected and the prevalence of targeted diseases in low-income countries will greatly stimulate the market demand for Peptide Therapeutics.

    This report elaborates on the current development of the Peptide Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AbbVie

    • Allergan

    • Roche

    • Merck

    • Takeda

    • The Medicines

    • Shire

    • Novartis

    • Teva

    • Ferring

    • J & J

    • AstraZeneca

    • Novo Nordisk

    By Type:

    • Oral

    • Injection

    • Other

    By Application:

    • Cardiovascular Disorder

    • Cancer

    • Central Nervous System

    • Others

    • Metabolic Disorders

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Peptide Therapeutics Market Overview 2018-2029

    • 1.1 China Peptide Therapeutics Industry Development Overview

    • 1.2 China Peptide Therapeutics Industry Development History

    • 1.3 China Peptide Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Peptide Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)

      • 1.4.2 China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Injection (2018-2029)

      • 1.4.3 China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China Peptide Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular Disorder (2018-2029)

      • 1.5.2 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.3 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Central Nervous System (2018-2029)

      • 1.5.4 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

    • 1.6 China Peptide Therapeutics Market Analysis by Region

      • 1.6.1 North China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Peptide Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Peptide Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Peptide Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Peptide Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Peptide Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Peptide Therapeutics Industry Development

    Chapter 3 Peptide TherapeuticsIndustry Chain Analysis

    • 3.1 Peptide Therapeutics Industry Chain

    • 3.2 Peptide Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Peptide Therapeutics Market

    • 3.3 Peptide Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Peptide Therapeutics Market

    Chapter 4 China Peptide Therapeutics Market, by Type

    • 4.1 China Peptide Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Peptide Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Peptide Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Peptide Therapeutics Production Volume and Growth Rate of Oral

      • 4.5.2 China Peptide Therapeutics Production Volume and Growth Rate of Injection

      • 4.5.3 China Peptide Therapeutics Production Volume and Growth Rate of Other

    Chapter 5 China Peptide Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Peptide Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Peptide Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Peptide Therapeutics Market Size and Growth Rate of Cardiovascular Disorder

      • 5.5.2 China Peptide Therapeutics Market Size and Growth Rate of Cancer

      • 5.5.3 China Peptide Therapeutics Market Size and Growth Rate of Central Nervous System

      • 5.5.4 China Peptide Therapeutics Market Size and Growth Rate of Others

      • 5.5.5 China Peptide Therapeutics Market Size and Growth Rate of Metabolic Disorders

    Chapter 6 China Peptide Therapeutics Market, by Region

    • 6.1 China Peptide Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Peptide Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Peptide Therapeutics Market Analysis

    • 7.1 North China Peptide Therapeutics Market, by Type

    • 7.2 North China Peptide Therapeutics Market, by Application

    Chapter 8 Central China Peptide Therapeutics Market Analysis

    • 8.1 Central China Peptide Therapeutics Market, by Type

    • 8.2 Central China Peptide Therapeutics Market, by Application

    Chapter 9 South China Peptide Therapeutics Market Analysis

    • 9.1 South China Peptide Therapeutics Market, by Type

    • 9.2 South China Peptide Therapeutics Market, by Application

    Chapter 10 East China Peptide Therapeutics Market Analysis

    • 10.1 East China Peptide Therapeutics Market, by Type

    • 10.2 East China Peptide Therapeutics Market, by Application

    Chapter 11 Northeast China Peptide Therapeutics Market Analysis

    • 11.1 Northeast China Peptide Therapeutics Market, by Type

    • 11.2 Northeast China Peptide Therapeutics Market, by Application

    Chapter 12 Southwest China Peptide Therapeutics Market Analysis

    • 12.1 Southwest China Peptide Therapeutics Market, by Type

    • 12.2 Southwest China Peptide Therapeutics Market, by Application

    Chapter 13 Northwest China Peptide Therapeutics Market Analysis

    • 13.1 Northwest China Peptide Therapeutics Market, by Type

    • 13.2 Northwest China Peptide Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AbbVie

        • 14.1.1 AbbVie Company Profile

        • 14.1.2 AbbVie Peptide Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Allergan

        • 14.2.1 Allergan Company Profile

        • 14.2.2 Allergan Peptide Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Roche

        • 14.3.1 Roche Company Profile

        • 14.3.2 Roche Peptide Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck

        • 14.4.1 Merck Company Profile

        • 14.4.2 Merck Peptide Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Takeda

        • 14.5.1 Takeda Company Profile

        • 14.5.2 Takeda Peptide Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 The Medicines

        • 14.6.1 The Medicines Company Profile

        • 14.6.2 The Medicines Peptide Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Shire

        • 14.7.1 Shire Company Profile

        • 14.7.2 Shire Peptide Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Novartis

        • 14.8.1 Novartis Company Profile

        • 14.8.2 Novartis Peptide Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Teva

        • 14.9.1 Teva Company Profile

        • 14.9.2 Teva Peptide Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Ferring

        • 14.10.1 Ferring Company Profile

        • 14.10.2 Ferring Peptide Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 J & J

        • 14.11.1 J & J Company Profile

        • 14.11.2 J & J Peptide Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 AstraZeneca

        • 14.12.1 AstraZeneca Company Profile

        • 14.12.2 AstraZeneca Peptide Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Novo Nordisk

        • 14.13.1 Novo Nordisk Company Profile

        • 14.13.2 Novo Nordisk Peptide Therapeutics Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Peptide Therapeutics Industry Research Conclusions

    • 15.2 Peptide Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Peptide Therapeutics Industry Market Size (2018-2029)

    • Figure China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Peptide Therapeutics Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular Disorder (2018-2029)

    • Figure China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Central Nervous System (2018-2029)

    • Figure China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

    • Figure North China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Peptide Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Peptide Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Peptide Therapeutics Market Share by Type in 2018

    • Figure China Peptide Therapeutics Market Share by Type in 2023

    • Figure China Peptide Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Peptide Therapeutics Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Peptide Therapeutics Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Peptide Therapeutics Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Peptide Therapeutics Market Share by Application in 2018

    • Figure China Peptide Therapeutics Market Share by Application in 2023

    • Figure China Peptide Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Peptide Therapeutics Market Size and Growth Rate of Cardiovascular Disorder (2018-2023)

    • Figure China Peptide Therapeutics Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Peptide Therapeutics Market Size and Growth Rate of Central Nervous System (2018-2023)

    • Figure China Peptide Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Peptide Therapeutics Market Size and Growth Rate of Metabolic Disorders (2018-2023)

    • Table China Peptide Therapeutics Production Volume by Region (2018-2023)

    • Table China Peptide Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Peptide Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Peptide Therapeutics Production Value by Region (2018-2023)

    • Table China Peptide Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Peptide Therapeutics Production Value Share by Region (2018-2023)

    • Table China Peptide Therapeutics Sales Volume by Region (2018-2023)

    • Table China Peptide Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Peptide Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Peptide Therapeutics Sales Value by Region (2018-2023)

    • Table China Peptide Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Peptide Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table North China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table South China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table East China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Peptide Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Peptide Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Peptide Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Peptide Therapeutics Sales Volume Share by Application (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table The Medicines Company Profile

    • Table The Medicines Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ferring Company Profile

    • Table Ferring Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table J & J Company Profile

    • Table J & J Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Peptide Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Peptide Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US